Physician

Carrie B. Chapman, M.D.

According to 2025 Medicare claims, Carrie Chapman, M.D. (NPI: 1396703732) practices cardiology in the Appleton, WI market, with the plurality of this provider's patient population coming from Outagamie, WI. This provider's primary affiliated billing organization is ASCENSION MEDICAL GROUP-FOX VALLEY WISCONSIN, INC (NPI: 1831890177; TIN: 391127163) and primary practice location at 54913-8517. Chapman is affiliated with the THEDACARE ACO (ACO ID: A4988) and Ascension Care Management Health Partners Wisconsin, LLC (ACO ID: A5329), participating under the MSSP model.

Chapman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,279 traditional Medicare patients, billed 12,555 HCPCS/CPT codes, and received $362,278 in Medicare payments. The top billing code was A9502 (Technetium tc-99m tetrofosmin, diagnostic, per study dose). Part D data shows 8,537 prescription claims across 1,249 beneficiaries totaling $1,883,297 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 16 records totaling $429. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $71,762 to $362,278. Similarly, Part D prescription costs have moved sharply higher in recent years, from $165,194 to $1,883,297. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	962	1,544	$71,762
2016	918	1,520	$72,651
2017	916	1,421	$70,053
2018	951	1,492	$74,920
2019	726	3,525	$145,283
2020	1,202	11,125	$282,460
2021	1,365	12,165	$305,907
2022	1,327	10,532	$343,044
2023	1,461	13,594	$451,972
2024	1,279	12,555	$362,278

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	493	4,150	$165,194
2016	507	3,973	$194,322
2017	539	4,403	$228,226
2018	577	4,607	$322,665
2019	692	4,153	$426,946
2020	931	5,519	$687,583
2021	1,082	6,745	$997,137
2022	1,140	7,363	$1,325,654
2023	1,202	7,767	$1,603,329
2024	1,249	8,537	$1,883,297

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	197	397	$306
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	246	248	$264
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	360	364	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	518	676	$84
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	222	226	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,124	65,544	$1,230,811
Xarelto	Rivaroxaban	215	12,509	$222,152
Entresto	Sacubitril/Valsartan	114	5,920	$120,089
Jardiance	Empagliflozin	67	3,275	$62,050
Repatha Sureclick	Evolocumab	44	1,820	$34,837

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$429	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carrie B. Chapman, M.D.?

Tedicare shows public-source Medicare data for Carrie B. Chapman, M.D. (NPI 1396703732), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carrie B. Chapman, M.D. have ACO affiliation data?

Carrie B. Chapman, M.D. is shown with ACO affiliation data for THEDACARE ACO (MSSP, ACO ID A4988) and Ascension Care Management Health Partners Wisconsin, LLC (MSSP, ACO ID A5329).

What billing organization is linked to Carrie B. Chapman, M.D.?

Carrie B. Chapman, M.D. is linked to ASCENSION MEDICAL GROUP-FOX VALLEY WISCONSIN, INC (billing NPI 1831890177) in the available physician profile data.

Does Carrie B. Chapman, M.D. have Open Payments data?

Carrie B. Chapman, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.